Breaking News Instant updates and real-time market news.

CVS

CVS Health

$73.71

0.65 (0.89%)

, AET

Aetna

$199.39

1.155 (0.58%)

07:51
11/06/18
11/06
07:51
11/06/18
07:51

CVS Health says impact from Aetna to be dilutive to Q4, FY18 adjusted EPS

Says expects to issue approximately 285M shares. Says there will be a slight increase in the combined company tax rate relative to the CVS standalone rate.

CVS

CVS Health

$73.71

0.65 (0.89%)

AET

Aetna

$199.39

1.155 (0.58%)

  • 06

    Nov

CVS CVS Health
$73.71

0.65 (0.89%)

10/31/18
PIPR
10/31/18
DOWNGRADE
Target $206
PIPR
Neutral
Piper downgrades Aetna to Neutral on confidence of CVS deal closing
Piper Jaffray analyst Sarah James last night downgraded Aetna (AET) to Neutral from Overweight and lowered her price target for the shares to $206 from $212. The analyst is favorable on the fundamentals of Aetna's business and is confident the CVS Health (CVS) takeover will close given the recent Department of Justice approval. She believes Aetna shares will be range bound near the $206 per share takeout price.
10/25/18
WOLF
10/25/18
INITIATION
WOLF
Peer Perform
CVS Health initiated with a Peer Perform at Wolfe Research
Wolfe Research analyst Justin Lake assumed coverage on CVS Health with a Peer Perform citing moderating 2019 business momentum and limited growth visibility across the pharmacy and PBM businesses.
10/22/18
FBCO
10/22/18
NO CHANGE
Target $207
FBCO
Neutral
Aetna price target raised to $207 from $202 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Aetna (AET) to $207 from $202, while reiterating a Neutral rating on the shares. The analyst noted that the DOJ preliminary approved CVS' (CVS) acquisition of Aetna after the latter reached an agreement to sell its Medicare Part D drug plan business to WellCare Health Plans. Connecticut approved the CVS-AET deal October 17, and New York is expected to reach a decision after October 25, Rice adds. At this point, the analyst feels deal approval has a high probability of occurring, albeit the timing could be slightly later than CVS' outlook of early Q4 closing. Overall, Rice is putting a 90%-95% probability on the deal closure.
09/20/18
LEER
09/20/18
NO CHANGE
Target $250
LEER
Outperform
Cigna price target raised to $250 from $235 at Leerink
Leerink analyst Ana Gupte raised her price target on Outperform-rated Cigna (CI) to $250 from $235 following meetings with a panel of PBM and Specialty Rx specialists, which increased her bullishness on Cigna and Market Perform-rated Express Scripts (ESRX). In a research note to investors, Gupte says she also came away with raised confidence on the achiveability of the $4B annual drug cost savings from the Express Scripts switch by Anthem (ANTM) to IngenioRx in partnership with CVS (CVS). She adds that smaller independent PBMs still have niche opportunities with smaller regional third-party health plans, noting that Magellan Health (MGLN) is well positioned in this market, though loss of substantial business in Florida Seriously Mentally Ill is a headwind in Rx as well.
AET Aetna
$199.39

1.155 (0.58%)

10/30/18
PIPR
10/30/18
DOWNGRADE
Target $206
PIPR
Neutral
Aetna downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Sarah James downgraded Aetna to Neutral and lowered her price target to $206 from $212.
10/02/18
LEER
10/02/18
NO CHANGE
LEER
Outperform
Intersect ENT's Sinuva reimbursement policies 'steps in right direction,' says Leerink
Leerink analyst Richard Newitter reiterates an Outperform rating on Intersect ENT following some positive progress on the reimbursement front for Sinuva in the last several weeks, namely Aetna (AET) covering Sinuva and Anthem (ATNM) adding it to its formulary this past week. The analyst believes these positive coverage policies represent steps in the right direction to a potentially quicker and more consistent reimbursement process using the specialty pharmacy channel, an area where the company has faced some challenges.

TODAY'S FREE FLY STORIES

14:05
12/13/18
12/13
14:05
12/13/18
14:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

14:01
12/13/18
12/13
14:01
12/13/18
14:01
General news
Treasury Budget data reported »

November Treasury Budget…

DFFN

Diffusion Pharmaceuticals

$0.23

0.0176 (8.32%)

14:01
12/13/18
12/13
14:01
12/13/18
14:01
Hot Stocks
Diffusion Pharmaceuticals announces 1-for-15 reverse stock split »

Diffusion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$54.38

0.35 (0.65%)

14:00
12/13/18
12/13
14:00
12/13/18
14:00
Options
Notable call activity in Restaurant Brands as bullish position is adjusted »

Notable call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$55.27

-0.19 (-0.34%)

, WYNN

Wynn Resorts

$108.68

-0.79 (-0.72%)

13:59
12/13/18
12/13
13:59
12/13/18
13:59
Periodicals
Chanos shorting Wynn Resorts, Las Vegas Sands amid trade war, CNBC reports »

Short-seller Jim Chanos…

LVS

Las Vegas Sands

$55.27

-0.19 (-0.34%)

WYNN

Wynn Resorts

$108.68

-0.79 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.80

0.7 (1.06%)

13:56
12/13/18
12/13
13:56
12/13/18
13:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees growing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

SBUX

Starbucks

$66.81

0.71 (1.07%)

13:56
12/13/18
12/13
13:56
12/13/18
13:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

13:55
12/13/18
12/13
13:55
12/13/18
13:55
General news
U.S. equities remain mixed after rotating lower »

U.S. equities remain…

CSTM

Constellium

$8.39

-0.02 (-0.24%)

13:51
12/13/18
12/13
13:51
12/13/18
13:51
Hot Stocks
Constellium trading higher by 1.67% during 2018 Analyst Day presentation »

Constellium management is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 18

    Dec

SBUX

Starbucks

$66.67

0.57 (0.86%)

13:45
12/13/18
12/13
13:45
12/13/18
13:45
Hot Stocks
Starbucks CEO says customer behaviors shifting rapidly, company must adapt »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

ADBE

Adobe

$245.82

0.38 (0.15%)

, COST

Costco

$225.99

-1.83 (-0.80%)

13:42
12/13/18
12/13
13:42
12/13/18
13:42
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$245.82

0.38 (0.15%)

COST

Costco

$225.99

-1.83 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.81

-0.72 (-0.27%)

13:40
12/13/18
12/13
13:40
12/13/18
13:40
Options
Four-day hedge opened in SPYders »

Four-day hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$109.16

-0.31 (-0.28%)

, LVS

Las Vegas Sands

$55.16

-0.3 (-0.54%)

13:36
12/13/18
12/13
13:36
12/13/18
13:36
Periodicals
Breaking Periodicals news story on Wynn Resorts, Las Vegas Sands »

Chanos shorting Wynn…

WYNN

Wynn Resorts

$109.16

-0.31 (-0.28%)

LVS

Las Vegas Sands

$55.16

-0.3 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$22.72

0.82 (3.74%)

13:30
12/13/18
12/13
13:30
12/13/18
13:30
Options
Call spreads in JD as shares gain 3.5% and a bullish position is adjusted »

Call spreads in JD as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$2.98

-0.11 (-3.56%)

13:29
12/13/18
12/13
13:29
12/13/18
13:29
Hot Stocks
Hill International selected by the ERBD to provide railway supervision services »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBAI

Lakeland Bancorp

$14.83

-0.27 (-1.79%)

13:27
12/13/18
12/13
13:27
12/13/18
13:27
Hot Stocks
Highlands Bancorp investors approve merger with Lakeland Bancorp »

Lakeland Bancorp and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$25.70

-0.36 (-1.38%)

, BX

Blackstone

$30.22

-0.28 (-0.92%)

13:24
12/13/18
12/13
13:24
12/13/18
13:24
Periodicals
Nielsen to hold talks with potential buyers in January, CNBC says »

Nielsen (NLSN) intends to…

NLSN

Nielsen

$25.70

-0.36 (-1.38%)

BX

Blackstone

$30.22

-0.28 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$66.44

-1.36 (-2.01%)

, WMT

Walmart

$92.78

-0.34 (-0.37%)

13:23
12/13/18
12/13
13:23
12/13/18
13:23
Hot Stocks
New York AG sues Target, Walmart over lead-contaminated toy sales »

New York Attorney General…

TGT

Target

$66.44

-1.36 (-2.01%)

WMT

Walmart

$92.78

-0.34 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

HIIQ

Health Insurance Innovations

$29.08

-0.985 (-3.28%)

13:21
12/13/18
12/13
13:21
12/13/18
13:21
Hot Stocks
Breaking Hot Stocks news story on Health Insurance Innovations »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MET

MetLife

$39.30

-0.27 (-0.68%)

13:20
12/13/18
12/13
13:20
12/13/18
13:20
Options
Call buyer in MetLife lays out $57K for one-day trade »

Call buyer in MetLife…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HIIQ

Health Insurance Innovations

$29.08

-0.985 (-3.28%)

13:20
12/13/18
12/13
13:20
12/13/18
13:20
Hot Stocks
Breaking Hot Stocks news story on Health Insurance Innovations »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/13/18
12/13
13:17
12/13/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/13/18
12/13
13:16
12/13/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MELI

MercadoLibre

$338.18

-23.4 (-6.47%)

13:15
12/13/18
12/13
13:15
12/13/18
13:15
Options
MercadoLibre put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
12/13/18
12/13
13:15
12/13/18
13:15
General news
Treasury's $16 B 30-year reopening was ok, but nothing special »

Treasury's $16 B…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.